© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Vera Therapeutics, Inc. (VERA) shows an Average True Range (ATR) of 2.88 and an Enterprise Value of 2.2B. Its average trading volume over the past 3 months is 1.55M, indicating liquidity. These fundamental metrics provide insight into VERA's underlying financial health and market activity.
Vera Therapeutics, Inc. (VERA) technical indicators as of December 22, 2025: the SMA 20 is 23.72%, SMA 50 at 51.43%, and SMA 200 at 95.49%. The RSI 14 value is 78.61, suggesting its current momentum. These technical analysis signals help assess VERA's price trends and potential future movements.
Vera Therapeutics, Inc. (VERA) stock performance overview as of December 22, 2025: The 52-week high is $51.72 (currently 0.06% below), and the 52-week low is $18.53 (currently 176.42% above). Over the past year, VERA's performance is 16.28%, compared to the S&P 500's 12.87% change.
According to market data, Vera Therapeutics, Inc. (VERA) stock's recent performance metrics show that over the last month, VERA is 77.17%, with a Year-to-Date (YTD) performance of 21.12%. Over the past year, the stock has seen a 16.28% change. These figures summarize VERA's price movements across various periods, reflecting its historical returns.
According to current financial data, VERA stock's P/E (TTM) ratio is -14.97, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for VERA, including P/S (N/A), P/B (6.98), and P/FCF (-15.49), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.